Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)

NCT00243178 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

6706

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Vascular Risk

Interventions

DRUG: clopidogrel (SR25990C)

Sponsor

Sanofi

Collaborators

[object Object]